Informed lay preferences for delivery of racially varied pharmacogenomics
Authors:
- Jennifer L. BevanJBJennifer L. Bevan
- Jonh A. LynchJLJonh A. Lynch
- 1 September 2003
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 5 (5) , 393-399
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Race, Ethnicity, and Health: Can Genetics Explain Disparities?Perspectives in Biology and Medicine, 2002
- Population genetic structure of variable drug responseNature Genetics, 2001
- Racial Differences in the Response to Drugs — Pointers to Genetic DifferencesNew England Journal of Medicine, 2001
- Racial Profiling in Medical ResearchNew England Journal of Medicine, 2001
- Lesser Response to Angiotensin-Converting–Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular DysfunctionNew England Journal of Medicine, 2001
- Why genes don't count (for racial differences in health)American Journal of Public Health, 2000
- “What Do You Think about Genetic Medicine?” Facilitating Sociable Public Discourse on Developments in the New GeneticsScience, Technology, & Human Values, 2000
- Drawing the line: an analysis of lay people's discussions about the new geneticsPublic Understanding of Science, 1998
- Public understanding of the new genetics1996
- Public attitudes toward genetic testingPopulation Research and Policy Review, 1991